Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CRIS compared with RADX: revenue, margins and what each company keeps, and the suppliers and customers both name
CRIS
Curis Inc
Change
Mkt cap
Revenue
Revenue
RADX
Radiopharm Theranostics Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
CRIS
Curis Inc
vs
RADX
Radiopharm Theranostics Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CRIS
1
—
Genentech
unlisted
customer
Shared
0
No shared counterparties.
Only RADX
3
—
AtomVie
unlisted
supplier
—
Diaprost AB
unlisted
supplier
—
Lantheus
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
CRIS
Curis Inc
Change
1.18
▲
+65.29%
Mkt cap
$1.5M
Revenue
$1M
Q4 FY25
Revenue
$9M
FY25
RADX
Radiopharm Theranostics Ltd
Change
0.86
▼
−3.16%
Regular session
Nov 4 '26
Mkt cap
$3.5B
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 4 '26
CRIS
Curis Inc
vs
RADX
Radiopharm Theranostics Ltd
1.18
▲
+65.29%
Price
0.86
▼
−3.16%
$1.5M
Mkt cap
$3.5B
Q4 FY25
$1M
Revenue
—
FY25
$9M
Revenue
—
Change
Change
CRIS
1.18
▲
+65.29%
vs
RADX
0.86
▼
−3.16%
Regular session
Nov 4 '26